With SIDF funding, and all licensing in place as of Q4 2020 ended 2023, the founders have now broken ground.
The industry specific plant will be the newest major, effective-capacity pharmaceutical manufacturing facility In Saudi Arabia.
This rare, early-stage investment opportunity is offered in a highly desirable global growth industry.
We are now open for discussion with qualified investors for new capital investment through private equity for Phase Two.
This capital expansion will develop the next line using the latest industry-specific technical advances and formulation protocols.
For information on investing in DDC contact: info@drugd.com.sa
© Copyright 2024. DDC LLC All Rights Reserved.